New molecular marker for prostate cancer
This article was originally published in Clinica
Executive Summary
US researchers have discovered a new protein marker for prostate cancer. The marker could help doctors predict whether patients with tumours which have not spread are more likely to die from the disease. Testing for the marker could pick out patients who need aggressive therapy during the early stages of the disease, allowing others to avoid these intensive and expensive treatments.